{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:23:45Z","timestamp":1771489425515,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/D\/NZ7\/03636"],"award-info":[{"award-number":["2016\/23\/D\/NZ7\/03636"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.mcn.2022.103728","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T11:26:28Z","timestamp":1649676388000},"page":"103728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor"],"prefix":"10.1016","volume":"120","author":[{"given":"Joanna","family":"Matali\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr F.J.","family":"Lipi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2022.103728_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152324","article-title":"Amelioration of ochratoxin-a induced cytotoxicity by prophylactic treatment of N-acetyl-L-tryptophan in human embryonic kidney cells","volume":"429","author":"Agarwal","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.mcn.2022.103728_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.23300","article-title":"Blood\u2013brain barrier and traumatic brain injury","volume":"92","author":"Alves","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0196-9781(99)00082-0","article-title":"Receptor subtypes involved in tachykinin-mediated edema formation\u2606","volume":"20","author":"Alves","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.mcn.2022.103728_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1684\/mrh.2017.0427","article-title":"Magnesium enhances the beneficial effects of NK1 antagonist administration on blood\u2013brain barrier permeability and motor outcome after traumatic brain injury","volume":"30","author":"Ameliorate","year":"2017","journal-title":"Magnes. Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-5728(02)00262-X","article-title":"Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium","volume":"131","author":"Annunziata","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.mcn.2022.103728_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00044-005-0132-0","article-title":"A comparative study: evaluation of antioxidant activity of melatonin and some indole derivatives","volume":"14","author":"Ate\u015f-Alag\u00f6z","year":"2005","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2011.02.082","article-title":"Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage","volume":"1389","author":"Barry","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.freeradbiomed.2020.09.002","article-title":"Reactivity and degradation products of tryptophan in solution and proteins","volume":"160","author":"Bellmaine","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2022.103728_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/biom9040142","article-title":"Receptor ligands as helping hands to L-DOPA in the treatment of Parkinson\u2019s disease","volume":"9","author":"Bello","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.mcn.2022.103728_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/039463200301600110","article-title":"The role of substance P in the cerebral ischemia","volume":"16","author":"Bruno","year":"2003","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.mcn.2022.103728_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2011.06.008","article-title":"Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of amyotrophic lateral sclerosis","volume":"44","author":"Caioli","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2022.103728_bb0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1054\/npep.2000.0823","article-title":"Neurokinin mediation of edema and inflammation","volume":"34","author":"Campos","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcn.2022.103728_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2012.04.028","article-title":"Substance P-induced changes in cell genesis following diffuse traumatic brain injury","volume":"214","author":"Carthew","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2022.103728_bb0070","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1016\/S0021-9258(17)37412-4","article-title":"Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor","volume":"269","author":"Cascieri","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jnr.21846","article-title":"Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury","volume":"87","author":"Cook","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1755-5949.2012.00332.x","article-title":"A substance P antagonist improves outcome in female Sprague dawley rats following diffuse traumatic brain injury","volume":"18","author":"Corrigan","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mcn.2022.103728_bb0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/bph.13155","article-title":"Inflammation in acute CNS injury: a focus on the role of substance P","volume":"173","author":"Corrigan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mcn.2022.103728_bb0090","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1038\/s41598-021-88237-0","article-title":"NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury","volume":"11","author":"Corrigan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2022.103728_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-8993(89)90032-2","article-title":"Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis","volume":"483","author":"Dietl","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11095-018-2467-5","article-title":"Mitigation of oxidation in therapeutic antibody formulations: a biochemical efficacy and safety evaluation of N-acetyl-tryptophan and L-methionine","volume":"35","author":"Dion","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0b013e328337f451","article-title":"Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments","volume":"23","author":"Donkin","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.mcn.2022.103728_bb0110","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/jcbfm.2009.63","article-title":"Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury","volume":"29","author":"Donkin","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.mcn.2022.103728_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/neu.2010.1632","article-title":"A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury","volume":"28","author":"Donkin","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.mcn.2022.103728_bb0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15376516.2017.1411412","article-title":"N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats","volume":"28","author":"Fernandes","year":"2018","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.mcn.2022.103728_bb0125","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/acs.jmedchem.0c02227","article-title":"Decision making in structure-based drug discovery: visual inspection of docking results","volume":"64","author":"Fischer","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0130","series-title":"Brain Edema XV","first-page":"201","article-title":"Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure","author":"Gabrielian","year":"2013"},{"key":"10.1016\/j.mcn.2022.103728_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s004010050988","article-title":"Substance P-induced enhanced permeability of dura mater microvessels is accompanied by pronounced ultrastructural changes, but is not dependent on the density of endothelial cell anionic sites","volume":"97","author":"Ghabriel","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2022.103728_bb0140","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0145","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/mp4007375","article-title":"Screening methods to identify indole derivatives that protect against reactive oxygen species induced tryptophan oxidation in proteins","volume":"11","author":"Grewal","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mcn.2022.103728_bb0150","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.3390\/molecules25163756","article-title":"Radiochemical synthesis and evaluation of novel radioconjugates of neurokinin 1 receptor antagonist aprepitant dedicated for NK1R-positive tumors","volume":"25","author":"Halik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mcn.2022.103728_bb0155","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s13311-019-00779-4","article-title":"The medical Management of Cerebral Edema: past, present, and future therapies","volume":"16","author":"Halstead","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mcn.2022.103728_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2010.06.044","article-title":"Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury","volume":"481","author":"Harford-Wright","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2022.103728_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097002","article-title":"Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors","volume":"9","author":"Harford-Wright","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2022.103728_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2015.12.024","article-title":"Therapies negating neuroinflammation after brain trauma","volume":"1640","author":"Hellewell","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0175","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s13311-021-01077-8","article-title":"Neurokinin receptor 1 (NK1R) antagonist aprepitant enhances hematoma clearance by regulating microglial polarization via PKC\/p38MAPK\/NF\u03baB pathway after experimental intracerebral hemorrhage in mice","volume":"18","author":"Jin","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mcn.2022.103728_bb0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2015.10.006","article-title":"Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer\u2019s disease","volume":"609","author":"Johansson","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2022.103728_bb0185","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nlm.2006.09.007","article-title":"Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism","volume":"87","author":"Kart-Teke","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.mcn.2022.103728_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10787-016-0271-6","article-title":"Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms","volume":"24","author":"Kaur","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.mcn.2022.103728_bb0195","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1074\/jbc.M009462200","article-title":"Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+\/monocarboxylate transporters","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0200","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.bbagen.2014.04.014","article-title":"N-acetyl-l-methionine is a superior protectant of human serum albumin against photo-oxidation and reactive oxygen species compared to N-acetyl-l-tryptophan","volume":"1840","author":"Kouno","year":"2014","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.mcn.2022.103728_bb0205","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/jm060999m","article-title":"Prediction of Protein\u2212Ligand interactions. Docking and scoring: successes and gaps","volume":"49","author":"Leach","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0210","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bcp.2009.01.020","article-title":"Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3","volume":"77","author":"Leffler","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mcn.2022.103728_bb0215","series-title":"Brain Edema XV","first-page":"303","article-title":"The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury","author":"Leonard","year":"2013"},{"key":"10.1016\/j.mcn.2022.103728_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098364","article-title":"NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury","volume":"9","author":"Leonard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2022.103728_bb0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm00006a011","article-title":"Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the Ester linkage","volume":"38","author":"Lewis","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2012.06.001","article-title":"Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours","volume":"250","author":"Lewis","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.mcn.2022.103728_bb0235","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/CAD.0b013e32835ef440","article-title":"NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer","volume":"24","author":"Lewis","year":"2013","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.mcn.2022.103728_bb0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2015.05.002","article-title":"N-acetyl-l-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model","volume":"80","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2022.103728_bb0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2018.12.018","article-title":"Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice","volume":"107","author":"Li","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mcn.2022.103728_bb0250","article-title":"Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against ischemia-reperfusion injury in rats","volume":"8","author":"Li","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.mcn.2022.103728_bb0255","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13054-015-0911-z","article-title":"Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury","volume":"19","author":"Lorente","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.mcn.2022.103728_bb0260","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/ijms17060991","article-title":"Serum levels of substance P and mortality in patients with a severe acute ischemic stroke","volume":"17","author":"Lorente","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2022.103728_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104893","article-title":"Serum substance P levels and early mortality of spontaneous intracerebral haemorrhage patients","volume":"29","author":"Lorente","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.mcn.2022.103728_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcrc.2020.01.022","article-title":"High serum substance P levels and mortality after malignant middle cerebral artery infarction","volume":"57","author":"Lorente","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.mcn.2022.103728_bb0275","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1021\/jm00066a015","article-title":"N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists","volume":"36","author":"MacLeod","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0280","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/jm00035a006","article-title":"Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor","volume":"37","author":"MacLeod","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0285","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/jm00006a012","article-title":"Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan","volume":"38","author":"MacLeod","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0290","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s10989-020-10051-5","article-title":"Evaluation of receptor affinity, analgesic activity and cytotoxicity of a hybrid peptide, AWL3020","volume":"26","author":"Matali\u0144ska","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.mcn.2022.103728_bb0295","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ijms23031214","article-title":"Novel NK1R-targeted 68Ga-\/177Lu-radioconjugates with potential application against glioblastoma multiforme: preliminary exploration of structure-activity relationships","volume":"23","author":"Matali\u0144ska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2022.103728_bb0300","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s007020050214","article-title":"Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis","volume":"106","author":"Matsuishi","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mcn.2022.103728_bb0305","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0310","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/13543776.2020.1769599","article-title":"Neurokinin receptor antagonism: a patent review (2014-present)","volume":"30","author":"Mu\u00f1oz","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.mcn.2022.103728_bb0315","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.npep.2003.12.003","article-title":"Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats","volume":"38","author":"Nimmo","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcn.2022.103728_bb0320","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11909","article-title":"N-acetyl-L-tryptophan attenuates hepatic ischemia-reperfusion injury via regulating TLR4\/NLRP3 signaling pathway in rats","volume":"9","author":"Pan","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.mcn.2022.103728_bb0325","first-page":"61","article-title":"The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: involvement of aryl hydrocarbon receptor in mechanism of action","volume":"15","author":"Rael","year":"2018","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.mcn.2022.103728_bb0330","series-title":"International Neurotrauma Symposium","first-page":"115","article-title":"Inhibition of neurogenic inflammation attenuates the inflammatory response following traumatic brain injury in rats","volume":"2004","author":"Reardon","year":"2004"},{"key":"10.1016\/j.mcn.2022.103728_bb0335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11030-021-10276-6","article-title":"In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer\u2019s disease","volume":"26","author":"Satarker","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.mcn.2022.103728_bb0340","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mcn.2022.103728_bb0345","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/14756360802187612","article-title":"New tryptophanase inhibitors: towards prevention of bacterial biofilm formation","volume":"24","author":"Scherzer","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0350","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/07391102.2012.709460","article-title":"Molecular modeling, dynamics, and an insight into the structural inhibition of cofactor independent phosphoglycerate mutase isoform 1 from wuchereria bancrofti using cheminformatics and mutational studies","volume":"31","author":"Sharma","year":"2013","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.mcn.2022.103728_bb0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1476-5381.1993.tb13432.x","article-title":"The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats","volume":"108","author":"Shepheard","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mcn.2022.103728_bb0360","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jnc.13190","article-title":"N-acetyl- l -tryptophan, but not N-acetyl- d -tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis","volume":"134","author":"Sirianni","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2022.103728_bb0365","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/ijms18081788","article-title":"The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury","volume":"18","author":"Sorby-Adams","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2022.103728_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00681","article-title":"NK1-r antagonist treatment comparable to decompressive craniectomy in reducing intracranial pressure following stroke","volume":"13","author":"Sorby-Adams","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mcn.2022.103728_bb0375","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bjp.0704464","article-title":"Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat","volume":"135","author":"Souza","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mcn.2022.103728_bb0380","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/lt.22237","article-title":"Industrial stabilizers caprylate and N -acetyltryptophanate reduce the efficacy of albumin in liver patients","volume":"17","author":"Stange","year":"2011","journal-title":"Liver Transplant."},{"key":"10.1016\/j.mcn.2022.103728_bb0385","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.7b00226","article-title":"Analgesic properties of opioid\/NK1 multitarget ligands with distinct in vitro profiles in naive and chronic constriction injury (CCI)-mice","author":"Starnowska","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.mcn.2022.103728_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034138","article-title":"Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson\u2019s disease","volume":"7","author":"Thornton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2022.103728_bb0395","series-title":"Mechanisms in Parkinson\u2019s Disease - Models and Treatments","article-title":"The role of the neuropeptide substance P in the pathogenesis of Parkinson\u2019s disease","author":"Thornton","year":"2012"},{"key":"10.1016\/j.mcn.2022.103728_bb0400","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neulet.2010.06.057","article-title":"A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death","volume":"481","author":"Thornton","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2022.103728_bb0405","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.parkreldis.2014.02.008","article-title":"The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model","volume":"20","author":"Thornton","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mcn.2022.103728_bb0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(98)00770-8","article-title":"Activity of tachykinin NK1 and bradykinin B2 receptor antagonists, and an opioid ligand at different stimulation parameters in neurogenic inflammation in the rat","volume":"257","author":"Towler","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2022.103728_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2012.06.047","article-title":"Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats","volume":"220","author":"Turner","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2022.103728_bb0420","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.npep.2014.07.002","article-title":"NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke","volume":"48","author":"Turner","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcn.2022.103728_bb0425","series-title":"Brain Edema XIII","first-page":"263","article-title":"Increased substance P immunoreactivity and edema formation following reversible ischemic stroke","author":"Turner","year":"2006"},{"key":"10.1016\/j.mcn.2022.103728_bb0430","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2011.03.066","article-title":"A substance P antagonist improves outcome when administered 4h after onset of ischaemic stroke","volume":"1393","author":"Turner","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2022.103728_bb0435","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nurt.2009.10.018","article-title":"Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury","volume":"7","author":"Vink","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mcn.2022.103728_bb0440","series-title":"Abstracts of the 5th International Neurotrauma Symposium","first-page":"164","article-title":"Inhibition of neurogenic inflammation improves motor and cognitive outcome following diffuse traumatic brain injury","volume":"16","author":"Vink","year":"2000"},{"key":"10.1016\/j.mcn.2022.103728_bb0445","doi-asserted-by":"crossref","first-page":"538S","DOI":"10.1080\/07315724.2004.10719398","article-title":"A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats","volume":"23","author":"Vink","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.mcn.2022.103728_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00304","article-title":"The role of substance P in secondary pathophysiology after traumatic brain injury","volume":"8","author":"Vink","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mcn.2022.103728_bb0455","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","article-title":"Inhibitors of cytochrome c release with therapeutic potential for Huntington\u2019s disease","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2022.103728_bb0460","doi-asserted-by":"crossref","first-page":"020020","DOI":"10.1063\/1.5085533","article-title":"Protective role of N-acetyl-L-tryptophan against hepatic ischemia-reperfusion injury by the TLR4\/NF-\u039aB signaling pathway","volume":"2058","author":"Wang","year":"2019","journal-title":"AIP Conference Proceedings"},{"key":"10.1016\/j.mcn.2022.103728_bb0465","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/13880209.2019.1617750","article-title":"Protective role of N -acetyl- l -tryptophan against hepatic ischemia-reperfusion injury via the RIP2\/caspase-1\/IL-1\u03b2 signaling pathway","volume":"57","author":"Wang","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.mcn.2022.103728_bb0470","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nec.2016.05.008","article-title":"Cerebral edema in traumatic brain injury","volume":"27","author":"Winkler","year":"2016","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.mcn.2022.103728_bb0475","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/jm00027a027","article-title":"A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors","volume":"37","author":"Ye","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2022.103728_bb0480","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/00001756-199707070-00006","article-title":"Neurokinin-1 receptor antagonist SR140333","volume":"8","author":"Yu","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.mcn.2022.103728_bb0485","series-title":"Substance P Immunoreactivity Increases Following Human Traumatic Brain Injury","first-page":"211","author":"Zacest","year":"2010"},{"key":"10.1016\/j.mcn.2022.103728_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.646726","article-title":"The emerging role of neuropeptides in Parkinson\u2019s disease","volume":"13","author":"Zheng","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2022.103728_bb0495","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/j.wneu.2020.12.009","article-title":"Serum substance P concentration in children with traumatic brain injury: a first report","volume":"147","author":"Zhou","year":"2021","journal-title":"World Neurosurg."},{"key":"10.1016\/j.mcn.2022.103728_bb0500","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/ijms22041921","article-title":"Tryptophan metabolism via kynurenine pathway: role in solid organ transplantation","volume":"22","author":"Zulpaite","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743122000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743122000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:33Z","timestamp":1760922813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743122000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":100,"alternative-id":["S1044743122000343"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2022.103728","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2022.103728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103728"}}